查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1952482

全球製藥設備O型圈市場（依材料、產品類型、應用、最終用戶和銷售管道分類）預測（2026-2032）

O-Rings for Pharmaceutical Equipment Market by Material, Product Type, Application, End User, Sales Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，製藥設備 O 型圈市場價值將達到 3.5217 億美元，到 2026 年將成長至 3.7939 億美元，到 2032 年將達到 5.661 億美元，複合年成長率為 7.01%。

關鍵市場統計數據
基準年 2025 3.5217億美元
預計年份：2026年 3.7939億美元
預測年份 2032 5.661億美元
複合年成長率 (%) 7.01%

本文簡要介紹了O型圈的選擇和生命週期管理為何對製藥生產設備的性能和法規遵循至關重要。

O型圈是製藥設備中至關重要的小型零件，其密封性能直接關係到產品純度、製程效率和法規遵循。本執行摘要概述了製藥生產中O型圈的現狀，重點關注材料性能、應用特定要求以及影響採購和設計決策的商業性趨勢。其目標是清晰、實用地闡述影響密封技術策略採購、設計檢驗和生命週期管理的促進因素、風險因素和機會。

材料技術的進步、監管的日益嚴格以及供應鏈的現代化正在如何改變醫藥O型圈的規格製定方法和生命週期策略

受材料創新、日益嚴格的監管要求和不斷演變的供應鏈模式的驅動，製藥設備O型圈市場正經歷變革性的變化。含氟聚合物複合技術和工程矽橡膠混合物的進步提高了性能標準，使其在嚴苛的製程化學環境中擁有更長的使用壽命和更強的耐化學性。同時，生物相容性和可萃取物/可浸出物測試正從建議轉變為事實上的強制性要求，製造商也要求供應商提供更全面的文件和可追溯性。

評估近期關稅壓力如何影響受法規環境下聚合物密封組件的採購、庫存策略和認證流程。

美國近期加徵的關稅為包括O型圈在內的醫療器材用聚合物零件的全球籌資策略帶來了顯著的摩擦。關稅造成的成本壓力促使許多買家重新評估其供應商組合，並加快近岸外包或區域供應商的開發。這種轉變對認證時間表和庫存策略產生了重大影響，因為替代供應商通常必須經過廣泛的兼容性和可萃取物測試才能獲得監管認證。

基於綜合細分市場分析的觀點，結合材料化學、設備等級、密封件運作特性、最終用戶需求和銷售管道等因素的影響，為可執行的決策提供基礎。

細分市場分析表明，材料選擇、應用環境、產品類型、終端用戶行業和銷售管道對規格製定和籌資策略的影響各不相同。三元乙丙橡膠、氟橡膠、丁腈橡膠、聚四氟乙烯和矽橡膠等材料類別在耐化學性、耐熱性和可萃取物特性方面存在顯著差異，這些差異決定了它們是否適用於特定的製程化學和滅菌方法。因此，以材料為先的評估仍然是任何認證項目的基礎。

區域採購慣例和監管要求決定了全球醫藥中心供應商的能力、品質保證重點和物流策略。

區域趨勢對供應商生態系統、法規結構以及影響製藥設備O型圈採購的物流因素有著深遠的影響。在美洲，垂直整合的供應鏈和嚴格的監管合規性尤其重要，這推動了對能夠提供全面技術文件、本土製造地和快速響應的售後支援的供應商的需求。這些優勢尤其受到契約製造製造商和大型製藥企業的重視，因為他們希望最大限度地降低前置作業時間風險，並在審核中證明其供應鏈控制能力。

供應商的技術能力、合規性和服務導向產品/服務決定了密封件供應鏈中的競爭優勢和夥伴關係模式。

製藥設備O型圈供應商之間的競爭取決於技術能力、法規遵循和服務水準的綜合考量。市場領導透過在材料科學、檢驗的供應鏈、可萃取物和可浸出物測試、變更管理以及完善的文件體系（以支援可追溯性）方面的投入而脫穎而出。能夠證明其具備內部測試能力、支援法規文件編制並能快速交貨認證樣品的供應商，通常是面臨檢驗時間緊迫的原始設備製造商 (OEM) 和契約製造的首選合作夥伴。

整合工程、品質和採購的實際步驟，以提高密封解決方案的合格、可靠性和整體擁有成本。

產業領導者應採取果斷行動，協調工程、品質和採購職能，圍繞統一的O型圈規格、合格和生命週期管理方法展開工作。首先，應優先建立材料合格矩陣，明確將化學相容性、耐滅菌性和可萃取物特性與每個製程流程對應起來，從而減少供應商選擇和變更管理過程中的不確定性。同時，應透過基於績效的契約，將供應商責任納入合格通訊協定，包括抽樣、文件交付和審核權限等條款。

採用實證方法，結合關鍵相關人員訪談、技術文獻綜述和比較分析，得出具有實際操作意義的見解和建議。

本研究結合一手和二手資料，透過技術評估和相關人員諮詢，得出相關見解。一手資料包括對負責製藥製程中密封組件的工廠工程師、品質保證人員和採購經理進行的結構化訪談，以及與聚合物專家和第三方檢測實驗室的直接諮詢。這些工作為材料性能、合格障礙和供應商服務模式提供了切實可行的觀點。

簡要概述重點介紹了跨職能協作、供應商夥伴關係以及以材料為中心的合格，以確保醫療器材的持續合規性和性能。

總之，製藥設備O型圈面臨更高的技術嚴謹性和更完善的供應鏈策略的雙重壓力。材料創新和更嚴格的監管要求提高了產品合格的標準，而關稅和區域趨勢正在重塑採購慣例和供應商關係。所有這些因素共同凸顯了跨部門協作和策略供應商夥伴關係應優先考慮文件記錄、可追溯性和在特定製程條件下可驗證的效能。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 按材料分類的製藥設備O型圈市場

  • 三元乙丙橡膠
  • 氟橡膠
  • 丁腈橡膠
  • 聚四氟乙烯
  • 矽酮

9. 按產品類型分類的製藥設備 O 型環市場

  • 動態密封
    • 往復式密封
    • 旋轉密封
  • 靜壓密封

第10章 按應用分類的製藥設備O型圈市場

  • 圓柱
    • 油壓缸
    • 汽缸
  • 篩選
  • 混合器
    • 高剪切混合器
    • 螺旋帶式攪拌機
  • 泵浦
    • 離心式幫浦
    • 隔膜泵
    • 旋轉泵
  • 反應爐
    • 間歇式反應器
    • 連續反應器
  • 閥門
    • 球閥
    • 蝶閥
    • 隔膜閥

第11章 製藥設備O型圈市場（依最終用戶分類）

  • 原料藥
  • 生物技術
  • 最終配方
  • 學名藥

第12章 製藥設備O型圈市場銷售管道

  • 售後市場
  • OEM

第13章 製藥設備O型圈市場（依地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 製藥設備O型圈市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國製藥設備O型圈市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

16. 美國製藥設備 O 型環市場

第17章：中國製藥設備O型圈市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Ames Rubber Manufacturing Company
  • Apple Rubber Products Inc.
  • Bal Seal Engineering, Inc.
  • DuPont de Nemours, Inc.
  • ERIKS SE & Co. KG
  • Freudenberg Medical, LLC
  • Garlock Sealing Technologies
  • Greene, Tweed & Co.
  • IDEX Corporation
  • James Walker & Co Ltd
  • Lauren Manufacturing
  • MARCO Rubber & Plastic Products, Inc.
  • Minnesota Rubber & Plastics
  • Parker Hannifin Corporation
  • Precision Associates, Inc.
  • Saint-Gobain Performance Plastics Corporation
  • Semperit AG Holding
  • Trelleborg Sealing Solutions
Product Code: MRR-867BED9A9FB6

The O-Rings for Pharmaceutical Equipment Market was valued at USD 352.17 million in 2025 and is projected to grow to USD 379.39 million in 2026, with a CAGR of 7.01%, reaching USD 566.10 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 352.17 million
Estimated Year [2026] USD 379.39 million
Forecast Year [2032] USD 566.10 million
CAGR (%) 7.01%

A concise foundation explaining why O-ring selection and lifecycle management are mission-critical for pharmaceutical equipment performance and regulatory compliance

The O-ring is a small component with outsized importance in pharmaceutical equipment, where sealing integrity underpins product purity, process efficiency, and regulatory compliance. This executive summary frames the contemporary landscape for O-rings used in pharmaceutical manufacturing, emphasizing material performance, application-specific demands, and commercial dynamics that influence procurement and design decisions. The goal is to present a clear, actionable view of drivers, risk vectors, and opportunities that inform strategic sourcing, design validation, and lifecycle management for sealing technologies.

In pharmaceutical contexts, O-rings serve in environments ranging from low-pressure filtration assemblies to high-shear mixing and pressurized reactors. Consequently, selection criteria extend beyond simple price comparisons to include chemical compatibility, extractables and leachables profiles, sterilization resilience, and long-term mechanical stability. As a result, engineering teams and supply chain leaders must balance performance attributes with regulatory documentation and supplier control measures.

This introduction situates the reader for the subsequent sections by outlining the structural themes: material innovation and qualification, shifting trade and tariff considerations affecting supply chains, segmentation implications across material and application types, regional dynamics shaping supplier strategies, and recommended actions for industry stakeholders. The following content draws on recent technological advancements, evolving regulatory expectations, and commercial pressures to provide a cohesive foundation for decision-making in pharmaceutical sealing solutions.

How material advances, regulatory tightening, and supply chain modernization are jointly reshaping specification practices and lifecycle strategies for pharmaceutical O-rings

The O-ring landscape for pharmaceutical equipment is undergoing transformative shifts driven by materials innovation, heightened regulatory expectations, and evolving supply chain paradigms. Advancements in fluoropolymer formulations and engineered silicone blends have raised the performance baseline, enabling longer service intervals and improved chemical resistance in aggressive process chemistries. At the same time, biocompatibility and extractables and leachables testing are moving from recommended practice to de facto requirements, prompting manufacturers to demand more comprehensive supplier documentation and traceability.

Concurrently, manufacturing philosophies are emphasizing modularity and cleanability, which alters the mechanical stresses and sterilization regimes that seals must withstand. The proliferation of single-use and hybrid systems introduces novel sealing geometries and temporary-service expectations, reshaping qualification protocols. In parallel, procurement strategies are evolving: risk-aware sourcing and supplier diversification are being prioritized to mitigate geopolitical and logistical risks.

Finally, digital tools are enabling better predictive maintenance and part tracking, allowing organizations to move from calendar-based replacement to condition-based interventions. These shifts, taken together, are not incremental; they require coordinated changes in engineering, quality assurance, and procurement policies to capture performance gains while maintaining regulatory compliance. Leaders who align cross-functional processes with these trends can achieve measurable improvements in uptime, product safety, and total cost of ownership.

Assessing how recent tariff pressures are altering supplier selection, inventory strategies, and qualification processes for polymeric sealing components in regulated environments

Recent tariff measures in the United States have introduced notable friction into global sourcing strategies for polymeric components used in pharmaceutical equipment, including O-rings. Tariff-induced cost pressure has prompted many buyers to reassess supplier portfolios and to accelerate near-shoring or regional vendor development initiatives. This shift has material implications for qualification timelines and inventory policies, since alternative suppliers must often undergo extensive compatibility and extractables testing before being certified for use in regulated processes.

In response, some manufacturers have adopted hybrid procurement models that combine strategic safety stocks with demand-driven replenishment to buffer short-term disruptions without incurring prohibitive carrying costs. Moreover, the tariff environment has motivated a greater emphasis on supplier value-add beyond unit price, such as vendor-provided technical documentation, third-party testing support, and extended warranty or buy-back arrangements that lower total acquisition cost.

Regulatory and quality teams are also adapting by tightening supplier onboarding frameworks to account for the variability introduced by recertifying components from new geographic sources. Cross-functional alignment between procurement, engineering, and quality assurance is now essential to maintain continuous production while transitioning to suppliers that mitigate tariff exposure. Ultimately, tariff dynamics have elevated the importance of supplier resilience and technical partnership in the procurement of sealing components for pharmaceutical equipment.

A comprehensive segmentation-driven perspective that connects material chemistry, equipment class, sealing dynamics, end-user requirements, and sales channel implications for practical decision-making

Segment-driven insights reveal that material choice, application context, product type, end-user vertical, and sales channel each exert a distinct influence on specification and sourcing strategies. Material categories such as Ethylene Propylene Diene Monomer, Fluoroelastomers, Nitrile, Polytetrafluoroethylene, and Silicone differ markedly in chemical resistance, temperature tolerance, and extractables profiles, which in turn determine suitability for specific process chemistries and sterilization methods. Therefore, a material-first assessment remains foundational for any qualification program.

Application segmentation highlights that sealing requirements vary across Cylinders, Filters, Mixers, Pumps, Reactors, and Valves, with additional nuance where Cylinders include Hydraulic Cylinders and Pneumatic Cylinders, Mixers include High Shear Mixers and Ribbon Mixers, Pumps include Centrifugal Pumps, Diaphragm Pumps, and Rotary Pumps, Reactors include Batch Reactors and Continuous Reactors, and Valves include Ball Valves, Butterfly Valves, and Diaphragm Valves. Each of these equipment classes imposes particular mechanical, thermal, and chemical demands that must be reconciled with material performance and installation constraints.

Product-type differentiation between Dynamic Sealing and Static Sealing, with the Dynamic category further divided into Reciprocating Seals and Rotary Seals, frames the expected wear modes and testing approaches. End-user verticals such as Active Pharmaceutical Ingredients, Biotechnology, Finished Dosage, and Generic Pharmaceuticals have distinct regulatory priorities and process sensitivities that affect allowable material choices and documentation depth. Finally, sales-channel considerations-Aftermarket versus Original Equipment Manufacturer-shape lead times, warranty structures, and the level of manufacturer-provided technical support required for component adoption. Together, these segmentation lenses provide a robust framework for tailoring qualification, procurement, and lifecycle management practices.

Regional sourcing realities and regulatory expectations that determine supplier capabilities, quality assurance priorities, and logistics strategies across global pharmaceutical hubs

Regional dynamics exert a profound influence on supplier ecosystems, regulatory frameworks, and logistical considerations that affect the sourcing of O-rings for pharmaceutical equipment. In the Americas, there is a pronounced emphasis on vertically integrated supply chains and rigorous regulatory compliance, which drives demand for suppliers that offer comprehensive technical documentation, domestic manufacturing footprints, and rapid-response aftermarket support. These attributes are particularly valued by contract manufacturers and large pharmaceutical organizations seeking to minimize lead time risk and demonstrate supply chain control during audits.

Europe, Middle East & Africa combines stringent regulatory expectations with diverse national standards, which compels suppliers to provide harmonized documentation and to maintain robust quality management systems capable of addressing multiple jurisdictions. In addition, this region places a premium on sustainability credentials and material lifecycle transparency, which influences purchasing decisions where environmental considerations intersect with regulatory compliance.

Asia-Pacific remains a hub for polymer manufacturing innovation and cost-competitive production, while also showing rapid adoption of advanced polymer formulations and local testing capabilities. However, variability in supplier quality and differing national regulatory regimes necessitate rigorous supplier qualification and ongoing quality surveillance when sourcing from this region. Taken together, these regional characteristics should inform a differentiated sourcing strategy that balances cost, speed, regulatory risk, and supplier capability.

How supplier technical capability, regulatory support, and service-oriented offerings are defining competitive advantage and partnership models in sealing component supply chains

Competitive dynamics among firms supplying O-rings for pharmaceutical equipment are shaped by a combination of technical capability, regulatory support, and service delivery. Market leaders differentiate through investments in materials science, validated supply chains, and robust documentation that supports extractables and leachables testing, change control, and traceability. Suppliers that can demonstrate in-house testing, regulatory dossier support, and rapid turnarounds for qualification samples are often preferred partners for OEMs and contract manufacturers who face compressed validation timelines.

Mid-tier suppliers compete by offering specialization in niche materials or equipment classes, such as bespoke fluoroelastomer blends designed for specific solvent chemistries or custom flange geometries for rotary seals. These vendors frequently partner with third-party laboratories to augment credibility and provide focused technical packages for clients with narrow application profiles. Emerging entrants are capitalizing on digital enablement, offering part-coding, lifetime tracking, and analytics that facilitate predictive replacement and compliance reporting.

Across the supplier landscape, collaborative product development and value-added services-such as engineering support during design transfer, field failure analysis, and managed inventory programs-serve as differentiators. Buyers increasingly evaluate suppliers on their ability to act as technical partners rather than commodity vendors, and successful firms align commercial terms with demonstrable reductions in operational risk and total cost of ownership.

Actionable steps for integrating engineering, quality, and procurement to strengthen qualification, resilience, and total cost of ownership for sealing solutions

Industry leaders should take decisive action to align engineering, quality, and procurement functions around a unified approach to O-ring specification, qualification, and lifecycle management. First, prioritize material qualification matrices that explicitly map chemical compatibility, sterilization resilience, and extractables profiles against each process stream, thereby reducing ambiguity during supplier selection and change control. Concurrently, embed supplier accountability into qualification protocols through performance-based contracts that include sampling, documentation delivery timelines, and provisions for audit access.

Second, develop resilient sourcing strategies that combine regional diversification with strategic safety stocks calibrated to validated qualification timelines. This approach balances cost efficiency with operational continuity and mitigates exposure to geopolitical and tariff shocks. Third, invest in digital traceability and condition-monitoring systems that support a shift from time-based to condition-based replacement, enabling predictive maintenance that reduces unplanned downtime and optimizes inventory levels.

Finally, foster deeper technical partnerships with key suppliers by co-investing in application-specific testing, joint failure analysis, and shared documentation templates to accelerate qualification. These collaborative measures reduce time-to-qualification and improve the robustness of change-control processes. By implementing these recommendations, organizations can strengthen compliance posture, lower total cost of ownership, and increase operational resilience in pharmaceutical sealing applications.

An evidence-based approach combining primary stakeholder interviews, technical literature review, and comparative analysis to produce operationally relevant insights and recommendations

This research synthesizes primary and secondary inputs to arrive at insights grounded in technical evaluation and stakeholder consultation. Primary inputs include structured interviews with equipment engineers, quality assurance leads, and procurement managers responsible for sealing components in pharmaceutical operations, supplemented by direct consultations with polymer specialists and third-party test laboratories. These engagements provided practical perspectives on material performance, qualification hurdles, and supplier service models.

Secondary analysis incorporated publicly available regulatory guidance, peer-reviewed materials science literature, and trade publications that document advancements in elastomer and fluoropolymer formulations, sterilization compatibility studies, and extractables and leachables methodologies. In addition, trade data and logistics trend reports were reviewed to contextualize tariff and regional supply chain dynamics.

Analytical methods combined qualitative synthesis with comparative technical evaluation across segmentation dimensions, allowing for cross-validation of findings. Throughout, emphasis was placed on traceability of claims and practical applicability of recommendations, ensuring that conclusions are actionable for engineering, quality, and procurement professionals seeking to improve sealing reliability and supply chain robustness.

A concise wrap-up emphasizing cross-functional alignment, supplier partnership, and material-focused qualification to sustain compliance and performance in pharmaceutical equipment

In conclusion, O-rings for pharmaceutical equipment are subject to converging pressures that demand greater technical rigor and more sophisticated supply chain strategies. Material innovations and stricter regulatory expectations are elevating the bar for qualification, while tariff and regional dynamics are reshaping sourcing practices and supplier relationships. These forces collectively underscore the need for cross-functional alignment and strategic supplier partnerships that prioritize documentation, traceability, and demonstrable performance under process-specific conditions.

Organizations that adopt a segmentation-aware procurement strategy-one that accounts for material chemistry, equipment application, sealing dynamics, end-user requirements, and sales channel implications-will be better positioned to balance performance, compliance, and cost. Moreover, suppliers that offer technical support, validated testing, and digital traceability can transition from commodity vendors to strategic partners, enabling faster qualification and improved lifecycle outcomes.

Ultimately, by implementing the recommended actions-material-focused qualification matrices, resilient sourcing strategies, digital traceability, and supplier co-development-manufacturers can reduce operational risk, improve uptime, and maintain compliance in increasingly complex pharmaceutical manufacturing environments. These measures will ensure that a seemingly simple component continues to support the high standards of product safety and process reliability required in the industry.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. O-Rings for Pharmaceutical Equipment Market, by Material

  • 8.1. Ethylene Propylene Diene Monomer
  • 8.2. Fluoroelastomers
  • 8.3. Nitrile
  • 8.4. Polytetrafluoroethylene
  • 8.5. Silicone

9. O-Rings for Pharmaceutical Equipment Market, by Product Type

  • 9.1. Dynamic Sealing
    • 9.1.1. Reciprocating Seals
    • 9.1.2. Rotary Seals
  • 9.2. Static Sealing

10. O-Rings for Pharmaceutical Equipment Market, by Application

  • 10.1. Cylinders
    • 10.1.1. Hydraulic Cylinders
    • 10.1.2. Pneumatic Cylinders
  • 10.2. Filters
  • 10.3. Mixers
    • 10.3.1. High Shear Mixers
    • 10.3.2. Ribbon Mixers
  • 10.4. Pumps
    • 10.4.1. Centrifugal Pumps
    • 10.4.2. Diaphragm Pumps
    • 10.4.3. Rotary Pumps
  • 10.5. Reactors
    • 10.5.1. Batch Reactors
    • 10.5.2. Continuous Reactors
  • 10.6. Valves
    • 10.6.1. Ball Valves
    • 10.6.2. Butterfly Valves
    • 10.6.3. Diaphragm Valves

11. O-Rings for Pharmaceutical Equipment Market, by End User

  • 11.1. Active Pharmaceutical Ingredients
  • 11.2. Biotechnology
  • 11.3. Finished Dosage
  • 11.4. Generic Pharmaceuticals

12. O-Rings for Pharmaceutical Equipment Market, by Sales Channel

  • 12.1. Aftermarket
  • 12.2. Original Equipment Manufacturer

13. O-Rings for Pharmaceutical Equipment Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. O-Rings for Pharmaceutical Equipment Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. O-Rings for Pharmaceutical Equipment Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States O-Rings for Pharmaceutical Equipment Market

17. China O-Rings for Pharmaceutical Equipment Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Ames Rubber Manufacturing Company
  • 18.6. Apple Rubber Products Inc.
  • 18.7. Bal Seal Engineering, Inc.
  • 18.8. DuPont de Nemours, Inc.
  • 18.9. ERIKS SE & Co. KG
  • 18.10. Freudenberg Medical, LLC
  • 18.11. Garlock Sealing Technologies
  • 18.12. Greene, Tweed & Co.
  • 18.13. IDEX Corporation
  • 18.14. James Walker & Co Ltd
  • 18.15. Lauren Manufacturing
  • 18.16. MARCO Rubber & Plastic Products, Inc.
  • 18.17. Minnesota Rubber & Plastics
  • 18.18. Parker Hannifin Corporation
  • 18.19. Precision Associates, Inc.
  • 18.20. Saint-Gobain Performance Plastics Corporation
  • 18.21. Semperit AG Holding
  • 18.22. Trelleborg Sealing Solutions

LIST OF FIGURES

  • FIGURE 1. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY SALES CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY ETHYLENE PROPYLENE DIENE MONOMER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY ETHYLENE PROPYLENE DIENE MONOMER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY ETHYLENE PROPYLENE DIENE MONOMER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY FLUOROELASTOMERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY FLUOROELASTOMERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY FLUOROELASTOMERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY NITRILE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY NITRILE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY NITRILE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY POLYTETRAFLUOROETHYLENE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY POLYTETRAFLUOROETHYLENE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY POLYTETRAFLUOROETHYLENE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY SILICONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY SILICONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY SILICONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY DYNAMIC SEALING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY DYNAMIC SEALING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY DYNAMIC SEALING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY DYNAMIC SEALING, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY RECIPROCATING SEALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY RECIPROCATING SEALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY RECIPROCATING SEALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY ROTARY SEALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY ROTARY SEALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY ROTARY SEALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY STATIC SEALING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY STATIC SEALING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY STATIC SEALING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY CYLINDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY CYLINDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY CYLINDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY CYLINDERS, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY HYDRAULIC CYLINDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY HYDRAULIC CYLINDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY HYDRAULIC CYLINDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY PNEUMATIC CYLINDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY PNEUMATIC CYLINDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY PNEUMATIC CYLINDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY FILTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY FILTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY FILTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY MIXERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY MIXERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY MIXERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY MIXERS, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY HIGH SHEAR MIXERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY HIGH SHEAR MIXERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY HIGH SHEAR MIXERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY RIBBON MIXERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY RIBBON MIXERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY RIBBON MIXERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY PUMPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY PUMPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY PUMPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY PUMPS, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY CENTRIFUGAL PUMPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY CENTRIFUGAL PUMPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY CENTRIFUGAL PUMPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY DIAPHRAGM PUMPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY DIAPHRAGM PUMPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY DIAPHRAGM PUMPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY ROTARY PUMPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY ROTARY PUMPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY ROTARY PUMPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY REACTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY REACTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY REACTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY REACTORS, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY BATCH REACTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY BATCH REACTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY BATCH REACTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY CONTINUOUS REACTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY CONTINUOUS REACTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY CONTINUOUS REACTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY VALVES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY VALVES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY VALVES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY VALVES, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY BALL VALVES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY BALL VALVES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY BALL VALVES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY BUTTERFLY VALVES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY BUTTERFLY VALVES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY BUTTERFLY VALVES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY DIAPHRAGM VALVES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY DIAPHRAGM VALVES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY DIAPHRAGM VALVES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY ACTIVE PHARMACEUTICAL INGREDIENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY ACTIVE PHARMACEUTICAL INGREDIENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY ACTIVE PHARMACEUTICAL INGREDIENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY BIOTECHNOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY BIOTECHNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY BIOTECHNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY FINISHED DOSAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY FINISHED DOSAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY FINISHED DOSAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY GENERIC PHARMACEUTICALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY GENERIC PHARMACEUTICALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY GENERIC PHARMACEUTICALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY AFTERMARKET, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY AFTERMARKET, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY AFTERMARKET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY ORIGINAL EQUIPMENT MANUFACTURER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY ORIGINAL EQUIPMENT MANUFACTURER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY ORIGINAL EQUIPMENT MANUFACTURER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. AMERICAS O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 114. AMERICAS O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 115. AMERICAS O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. AMERICAS O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY DYNAMIC SEALING, 2018-2032 (USD MILLION)
  • TABLE 117. AMERICAS O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 118. AMERICAS O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY CYLINDERS, 2018-2032 (USD MILLION)
  • TABLE 119. AMERICAS O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY MIXERS, 2018-2032 (USD MILLION)
  • TABLE 120. AMERICAS O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY PUMPS, 2018-2032 (USD MILLION)
  • TABLE 121. AMERICAS O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY REACTORS, 2018-2032 (USD MILLION)
  • TABLE 122. AMERICAS O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY VALVES, 2018-2032 (USD MILLION)
  • TABLE 123. AMERICAS O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 124. AMERICAS O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. NORTH AMERICA O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. NORTH AMERICA O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY DYNAMIC SEALING, 2018-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 130. NORTH AMERICA O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY CYLINDERS, 2018-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY MIXERS, 2018-2032 (USD MILLION)
  • TABLE 132. NORTH AMERICA O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY PUMPS, 2018-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY REACTORS, 2018-2032 (USD MILLION)
  • TABLE 134. NORTH AMERICA O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY VALVES, 2018-2032 (USD MILLION)
  • TABLE 135. NORTH AMERICA O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 136. NORTH AMERICA O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. LATIN AMERICA O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. LATIN AMERICA O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY DYNAMIC SEALING, 2018-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 142. LATIN AMERICA O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY CYLINDERS, 2018-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY MIXERS, 2018-2032 (USD MILLION)
  • TABLE 144. LATIN AMERICA O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY PUMPS, 2018-2032 (USD MILLION)
  • TABLE 145. LATIN AMERICA O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY REACTORS, 2018-2032 (USD MILLION)
  • TABLE 146. LATIN AMERICA O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY VALVES, 2018-2032 (USD MILLION)
  • TABLE 147. LATIN AMERICA O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 148. LATIN AMERICA O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY DYNAMIC SEALING, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY CYLINDERS, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY MIXERS, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY PUMPS, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY REACTORS, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY VALVES, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY DYNAMIC SEALING, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY CYLINDERS, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPE O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY MIXERS, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPE O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY PUMPS, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPE O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY REACTORS, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPE O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY VALVES, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPE O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPE O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 173. MIDDLE EAST O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 174. MIDDLE EAST O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 175. MIDDLE EAST O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. MIDDLE EAST O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY DYNAMIC SEALING, 2018-2032 (USD MILLION)
  • TABLE 177. MIDDLE EAST O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 178. MIDDLE EAST O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY CYLINDERS, 2018-2032 (USD MILLION)
  • TABLE 179. MIDDLE EAST O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY MIXERS, 2018-2032 (USD MILLION)
  • TABLE 180. MIDDLE EAST O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY PUMPS, 2018-2032 (USD MILLION)
  • TABLE 181. MIDDLE EAST O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY REACTORS, 2018-2032 (USD MILLION)
  • TABLE 182. MIDDLE EAST O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY VALVES, 2018-2032 (USD MILLION)
  • TABLE 183. MIDDLE EAST O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 184. MIDDLE EAST O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 185. AFRICA O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 186. AFRICA O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 187. AFRICA O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. AFRICA O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY DYNAMIC SEALING, 2018-2032 (USD MILLION)
  • TABLE 189. AFRICA O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 190. AFRICA O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY CYLINDERS, 2018-2032 (USD MILLION)
  • TABLE 191. AFRICA O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY MIXERS, 2018-2032 (USD MILLION)
  • TABLE 192. AFRICA O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY PUMPS, 2018-2032 (USD MILLION)
  • TABLE 193. AFRICA O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY REACTORS, 2018-2032 (USD MILLION)
  • TABLE 194. AFRICA O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY VALVES, 2018-2032 (USD MILLION)
  • TABLE 195. AFRICA O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 196. AFRICA O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 197. ASIA-PACIFIC O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 198. ASIA-PACIFIC O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 199. ASIA-PACIFIC O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. ASIA-PACIFIC O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY DYNAMIC SEALING, 2018-2032 (USD MILLION)
  • TABLE 201. ASIA-PACIFIC O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 202. ASIA-PACIFIC O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY CYLINDERS, 2018-2032 (USD MILLION)
  • TABLE 203. ASIA-PACIFIC O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY MIXERS, 2018-2032 (USD MILLION)
  • TABLE 204. ASIA-PACIFIC O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY PUMPS, 2018-2032 (USD MILLION)
  • TABLE 205. ASIA-PACIFIC O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY REACTORS, 2018-2032 (USD MILLION)
  • TABLE 206. ASIA-PACIFIC O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY VALVES, 2018-2032 (USD MILLION)
  • TABLE 207. ASIA-PACIFIC O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 208. ASIA-PACIFIC O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 209. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 210. ASEAN O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 211. ASEAN O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 212. ASEAN O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. ASEAN O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY DYNAMIC SEALING, 2018-2032 (USD MILLION)
  • TABLE 214. ASEAN O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 215. ASEAN O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY CYLINDERS, 2018-2032 (USD MILLION)
  • TABLE 216. ASEAN O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY MIXERS, 2018-2032 (USD MILLION)
  • TABLE 217. ASEAN O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY PUMPS, 2018-2032 (USD MILLION)
  • TABLE 218. ASEAN O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY REACTORS, 2018-2032 (USD MILLION)
  • TABLE 219. ASEAN O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY VALVES, 2018-2032 (USD MILLION)
  • TABLE 220. ASEAN O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 221. ASEAN O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 222. GCC O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 223. GCC O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 224. GCC O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 225. GCC O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY DYNAMIC SEALING, 2018-2032 (USD MILLION)
  • TABLE 226. GCC O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 227. GCC O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY CYLINDERS, 2018-2032 (USD MILLION)
  • TABLE 228. GCC O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY MIXERS, 2018-2032 (USD MILLION)
  • TABLE 229. GCC O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY PUMPS, 2018-2032 (USD MILLION)
  • TABLE 230. GCC O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY REACTORS, 2018-2032 (USD MILLION)
  • TABLE 231. GCC O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY VALVES, 2018-2032 (USD MILLION)
  • TABLE 232. GCC O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 233. GCC O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 234. EUROPEAN UNION O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 235. EUROPEAN UNION O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 236. EUROPEAN UNION O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 237. EUROPEAN UNION O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY DYNAMIC SEALING, 2018-2032 (USD MILLION)
  • TABLE 238. EUROPEAN UNION O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 239. EUROPEAN UNION O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY CYLINDERS, 2018-2032 (USD MILLION)
  • TABLE 240. EUROPEAN UNION O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY MIXERS, 2018-2032 (USD MILLION)
  • TABLE 241. EUROPEAN UNION O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY PUMPS, 2018-2032 (USD MILLION)
  • TABLE 242. EUROPEAN UNION O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY REACTORS, 2018-2032 (USD MILLION)
  • TABLE 243. EUROPEAN UNION O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY VALVES, 2018-2032 (USD MILLION)
  • TABLE 244. EUROPEAN UNION O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 245. EUROPEAN UNION O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 246. BRICS O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 247. BRICS O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 248. BRICS O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 249. BRICS O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY DYNAMIC SEALING, 2018-2032 (USD MILLION)
  • TABLE 250. BRICS O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 251. BRICS O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY CYLINDERS, 2018-2032 (USD MILLION)
  • TABLE 252. BRICS O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY MIXERS, 2018-2032 (USD MILLION)
  • TABLE 253. BRICS O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY PUMPS, 2018-2032 (USD MILLION)
  • TABLE 254. BRICS O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY REACTORS, 2018-2032 (USD MILLION)
  • TABLE 255. BRICS O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY VALVES, 2018-2032 (USD MILLION)
  • TABLE 256. BRICS O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 257. BRICS O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 258. G7 O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 259. G7 O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 260. G7 O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 261. G7 O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY DYNAMIC SEALING, 2018-2032 (USD MILLION)
  • TABLE 262. G7 O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 263. G7 O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY CYLINDERS, 2018-2032 (USD MILLION)
  • TABLE 264. G7 O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY MIXERS, 2018-2032 (USD MILLION)
  • TABLE 265. G7 O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY PUMPS, 2018-2032 (USD MILLION)
  • TABLE 266. G7 O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY REACTORS, 2018-2032 (USD MILLION)
  • TABLE 267. G7 O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY VALVES, 2018-2032 (USD MILLION)
  • TABLE 268. G7 O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 269. G7 O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 270. NATO O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 271. NATO O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 272. NATO O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 273. NATO O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY DYNAMIC SEALING, 2018-2032 (USD MILLION)
  • TABLE 274. NATO O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 275. NATO O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY CYLINDERS, 2018-2032 (USD MILLION)
  • TABLE 276. NATO O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY MIXERS, 2018-2032 (USD MILLION)
  • TABLE 277. NATO O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY PUMPS, 2018-2032 (USD MILLION)
  • TABLE 278. NATO O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY REACTORS, 2018-2032 (USD MILLION)
  • TABLE 279. NATO O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY VALVES, 2018-2032 (USD MILLION)
  • TABLE 280. NATO O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 281. NATO O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 282. GLOBAL O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 283. UNITED STATES O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 284. UNITED STATES O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 285. UNITED STATES O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 286. UNITED STATES O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY DYNAMIC SEALING, 2018-2032 (USD MILLION)
  • TABLE 287. UNITED STATES O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 288. UNITED STATES O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SIZE, BY CYLINDERS, 2018-2032 (USD MILLION)
  • TABLE 289. UNITED STATES O-RINGS FOR PHARMACEUTICAL EQUIPMENT MARKET SI